Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy-Reference-Cited by-同舟云学术

Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy

Published:2002-12 Issue: Volume:25 Page:73-79
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Lackner Herwig,Moser Andrea,Benesch Martin,Deutsch Johann,Kessler Harald H,Kerbl Reinhold,Schwinger Wolfgang,Dornbusch Hans-Jürgen,Sovinz Petra,Urban Christian

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference32 articles.

1. Chronic liver disease after treatment of malignant diseases in children;Ballauff;Klin. Pädiatr.,1999

2. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B;Barbera;Hepatology,1994

3. Clinical experience with famciclovir against hepatitis B virus;Bartholomeusz;Intervirology,1997

4. Chronic hepatitis in childhood: the spectrum of the disease;Bortolotti;Gut,1988

5. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood;Bortolotti;Gastroenterology,1990

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11);Zeitschrift für Gastroenterologie;2021-07

2. 4. Österreichischer Konsensusbericht zur Diagnose und Therapie der Hepatitis B 2009;Wiener klinische Wochenschrift;2010-05

3. Five-year results of chronic hepatitis B infection treatment in children with cured cancer;Liver International;2006-12

4. Frequency and characteristics of hepatitis B infection in children with malignant diseases;Srpski arhiv za celokupno lekarstvo;2005

5. Review article: nucleoside analogues for the treatment of chronic hepatitis B;Alimentary Pharmacology & Therapeutics;2004-12